It is thought that leukemia stem cells (LSC) (primitive CML progenitor cells) may not be strictly addicted to BCR-ABL and to be able to bypass BCR-ABL signaling via other pathways when treated with TK inhibitors [29]. This evidence concerns the gene ABL1 and leukemia.